Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors

KL Hadingham, EM Garrett, KA Wafford, C Bain, RP Heavens, DJ Sirinathsinghji and PJ Whiting

Merck Sharp & Dohme Research Laboratories, Harlow, Essex, UK.

A cDNA encoding the human gamma-aminobutyric acidA (GABAA) receptor alpha 6 subunit has been cloned and sequenced. The deduced amino acid sequence of this cDNA shows 91.4% identity with the published rat alpha 6 subunit. In situ hybridization histochemistry reveals the alpha 6 mRNA to be located within the granule cell layer of the human cerebellar cortex. Recombinant human alpha 6 beta gamma 2S GABAA receptors have been expressed in both stably transfected cells and Xenopus oocytes, and the pharmacology of the benzodiazepine binding site has been determined. The recombinant receptor has a diazepam- insensitive pharmacology, with negligible affinity for a number of classic benzodiazepines. A number of compounds that bind to the benzodiazepine site potentiated the GABA response of alpha 6 beta 2 gamma 2 receptors. Most importantly, the classic benzodiazepine antagonist ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (Ro 15-1788) and the partial inverse agonist ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate (Ro 15-4513) both acted as agonists at the alpha 6 containing receptor. This observation demonstrates definitively that efficacy of benzodiazepine compounds cannot be generalized across receptor subtypes and may also help explain some of the behavioral effects that have been reported for these compounds.

Volume 49, Issue 2, pp. 253-259, 02/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Yamashita, W. Marszalec, J. Z. Yeh, and T. Narahashi Effects of Ethanol on Tonic GABA Currents in Cerebellar Granule Cells and Mammalian Cells Recombinantly Expressing GABAA Receptors J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 431 - 438. [Abstract] [Full Text] [PDF]

				S. i Storustovu and B. Ebert Pharmacological Characterization of Agonists at {delta}-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of {gamma}2 J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1351 - 1359. [Abstract] [Full Text] [PDF]

				G. R. Dawson, K. A. Maubach, N. Collinson, M. Cobain, B. J. Everitt, A. M. MacLeod, H. I. Choudhury, L. M. McDonald, G. Pillai, W. Rycroft, et al. An Inverse Agonist Selective for {alpha}5 Subunit-Containing GABAA Receptors Enhances Cognition J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1335 - 1345. [Abstract] [Full Text] [PDF]

				J. R. Atack, K. A. Wafford, S. J. Tye, S. M. Cook, B. Sohal, A. Pike, C. Sur, D. Melillo, L. Bristow, F. Bromidge, et al. TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for {alpha}2- and {alpha}3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 410 - 422. [Abstract] [Full Text] [PDF]

				R. Dias, W. F. A. Sheppard, R. L. Fradley, E. M. Garrett, J. L. Stanley, S. J. Tye, S. Goodacre, R. J. Lincoln, S. M. Cook, R. Conley, et al. Evidence for a Significant Role of {alpha}3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines J. Neurosci., November 16, 2005; 25(46): 10682 - 10688. [Abstract] [Full Text] [PDF]

				G. R. Dawson, K. A. Wafford, A. Smith, G. R. Marshall, P. J. Bayley, J. M. Schaeffer, P. T. Meinke, and R. M. McKernan Anticonvulsant and Adverse Effects of Avermectin Analogs in Mice Are Mediated through the gamma -Aminobutyric AcidA Receptor J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1051 - 1060. [Abstract] [Full Text]

				S. M. J. Dunn, M. Davies, A. L. Muntoni, and J. J. Lambert Mutagenesis of the Rat alpha 1 Subunit of the gamma -Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands Mol. Pharmacol., October 1, 1999; 56(4): 768 - 774. [Abstract] [Full Text]

				S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting, and K.A. Wafford Residues in Transmembrane Domains I and II Determine gamma -Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide Mol. Pharmacol., June 1, 1999; 55(6): 993 - 999. [Abstract] [Full Text]

				E. A. Barnard, P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson, and S. Z. Langer International Union of Pharmacology. XV. Subtypes of gamma -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function Pharmacol. Rev., June 1, 1998; 50(2): 291 - 314. [Abstract] [Full Text] [PDF]

				R. A. Harris, C. F. Valenzuela, S. Brozowski, L. Chuang, K. Hadingham, and P. J. Whiting Adaptation of gamma -Aminobutyric Acid Type A Receptors to Alcohol Exposure: Studies with Stably Transfected Cells J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 180 - 188. [Abstract] [Full Text]

				B. Ebert, S. A. Thompson, K. Saounatsou, R. McKernan, P. Krogsgaard-Larsen, and K. A. Wafford Differences in Agonist/Antagonist Binding Affinity and Receptor Transduction Using Recombinant Human gamma -Aminobutyric Acid Type A Receptors Mol. Pharmacol., December 1, 1997; 52(6): 1150 - 1156. [Abstract] [Full Text]

				P. B. Wingrove, S. A. Thompson, K. A. Wafford, and P. J. Whiting Key Amino Acids in the gamma  Subunit of the gamma -Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site Mol. Pharmacol., November 1, 1997; 52(5): 874 - 881. [Abstract] [Full Text]

				D. Belelli, J. J. Lambert, J. A. Peters, K. Wafford, and P. J. Whiting The interaction of the general anesthetic etomidate with the gamma -aminobutyric acid type A receptor is influenced by a single amino acid PNAS, September 30, 1997; 94(20): 11031 - 11036. [Abstract] [Full Text] [PDF]

				L. S. Aspinwall, I. Bermudez, L. A. King, and K. A. Wafford The Interactions of Hexachlorocyclohexane Isomers with Human gamma -Aminobutyric AcidA Receptors Expressed in Xenopus Oocytes J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1557 - 1564. [Abstract] [Full Text]

				R. Mäkelä, M. Uusi-Oukari, G. E. Homanics, J. J. Quinlan, L. L. Firestone, W. Wisden, and E. R. Korpi Cerebellar gamma -Aminobutyric Acid Type A Receptors: Pharmacological Subtypes Revealed by Mutant Mouse Lines Mol. Pharmacol., September 1, 1997; 52(3): 380 - 388. [Abstract] [Full Text]

				S. Bahn, A. Jones, and W. Wisden Directing gene expression to cerebellar granule cells using gamma -aminobutyric acid type A receptor alpha 6 subunit transgenes PNAS, August 19, 1997; 94(17): 9417 - 9421. [Abstract] [Full Text] [PDF]

				P. J. Whiting, G. McAllister, D. Vassilatis, T. P. Bonnert, R. P. Heavens, D. W. Smith, L. Hewson, R. O'Donnell, M. R. Rigby, D. J. S. Sirinathsinghji, et al. Neuronally Restricted RNA Splicing Regulates the Expression of a Novel GABAA Receptor Subunit Conferring Atypical Functional Properties J. Neurosci., July 1, 1997; 17(13): 5027 - 5037. [Abstract] [Full Text] [PDF]

				G. E. Homanics, C. Ferguson, J. J. Quinlan, J. Daggett, K. Snyder, C. Lagenaur, Z.-P. Mi, X.-H. Wang, D. R. Grayson, and L. L. Firestone Gene Knockout of the alpha 6 Subunit of the gamma -Aminobutyric Acid Type A Receptor: Lack of Effect on Responses to Ethanol, Pentobarbital, and General Anesthetics Mol. Pharmacol., April 1, 1997; 51(4): 588 - 596. [Abstract] [Full Text]

				A. Jones, E. R. Korpi, R. M. McKernan, R. Pelz, Z. Nusser, R. Makela, J. R. Mellor, S. Pollard, S. Bahn, F. A. Stephenson, et al. Ligand-Gated Ion Channel Subunit Partnerships: GABAA Receptor alpha 6 Subunit Gene Inactivation Inhibits delta  Subunit Expression J. Neurosci., February 15, 1997; 17(4): 1350 - 1362. [Abstract] [Full Text] [PDF]